BioNTech SE ADR (NASDAQ: BNTX) is -2.74% lower on its value in year-to-date trading and has touched a low of $76.53 and a high of $131.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNTX stock was last observed hovering at around $114.77 in the last trading session, with the day’s loss setting it -3.94%.
Currently trading at $110.83, the stock is -4.15% and -5.06% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing -3.43% at the moment leaves the stock 5.86% off its SMA200. BNTX registered 24.11% gain for a year compared to 6-month gain of 25.94%.
The stock witnessed a -5.39% loss in the last 1 month and extending the period to 3 months gives it a -5.44%, and is 1.87% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.12% over the week and 4.14% over the month.
BioNTech SE ADR (BNTX) has around 3082 employees, a market worth around $26.57B and $3.30B in sales. Profit margin for the company is -15.20%. Distance from 52-week low is 44.82% and -15.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-2.33%).
with sales reaching $1.15B over the same period.The EPS is expected to shrink by -181.62% this year, but quarterly earnings will post -30.65% year-over-year. Quarterly sales are estimated to shrink -22.03% in year-over-year returns.
The shares outstanding are 239.74M, and float is at 235.99M with Short Float at 1.28%.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4425 of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $384.89 million to account for 1.9922 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8216 and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2174 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
Still, SEC filings show that on Feb 20 ’25, Poetting Sierk (Officer) Proposed Sale 120,000 shares at an average price of $119.58 for $14.35 million. The insider now directly holds shares of BioNTech SE ADR (BNTX).
